Phase 2, Open-label Study of Crinecerfont in Adolescent Participants with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

Need to get in touch with us?

medinfo@neurocrine.com
1-877-641-3461